Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–19 of 19 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT04047641
- Conditions
- Acute Myeloid Leukemia, Blasts 20 Percent or More of Bone Marrow Nucleated Cells, Hematologic Diseases, +18 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT03589729
- Conditions
- Acute Myeloid Leukemia, Blast Crisis, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, +25 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT00801489
- Conditions
- Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1, +19 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT03214562
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, High Risk Myelodysplastic Syndrome, +7 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT03630991
- Conditions
- Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Blast Crisis, +35 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Not Yet Recruiting
Phase 1 Open-label Study of AMX-883 Alone in Participants With AML and High-risk MDS and in Combination in Participants With AML
NCT07723703
- Conditions
- Acute Myeloid Leukaemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
- Locations
-
Not specified
NCT07710534
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, High Risk Myelodysplastic Syndrome, +7 more
- Locations
-
- Virginia Commonwealth University Richmond, Virginia, United States
NCT03672539
- Conditions
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Bone Marrow Diseases, Chronic Disease, +18 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT03358719
- Conditions
- Acute Myeloid Leukemia, Anemia, Anemia, Refractory, +20 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
NCT02131597
- Conditions
- High Risk Myelodysplastic Syndrome
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT03047993
- Conditions
- Acute Myeloid Leukemia With Multilineage Dysplasia, Blasts 20-30 Percent of Bone Marrow Nucleated Cells, Blasts 20-30 Percent of Peripheral Blood White Cells, +18 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT01823198
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia, +36 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT03263637
- Conditions
- Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, B-Cell Non-Hodgkin Lymphoma, +42 more
- Locations
-
- Research Site Aachen, Germany
- Research Site Bonn, Germany
- Research Site Göttingen, Germany
- Research Site Heidelberg, Germany
NCT02029950
- Conditions
- Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Myelomonocytic Leukemia-2, +10 more
- Locations
-
- Yale University New Haven, Connecticut, United States
- Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
- UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
- Conditions
- Acute Myeloid Leukaemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
- Locations
-
- Aberdeen Royal Infirmary Aberdeen, United Kingdom
- Belfast City Hospital Belfast, United Kingdom
- Birmingham Heartlands Hospital Birmingham, United Kingdom
- Addenbrooke's Hospital Cambridge, United Kingdom
Active, Not Recruiting
Hu8F4 in Treating Patients With Advanced Hematologic Malignancies
NCT02530034
- Conditions
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Blast Crisis, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, +31 more
- Locations
-
- Augusta University Augusta, Georgia, United States
- Montefiore Medical Center, Albert Einstein College of Medicine The Bronx, New York, United States
- M D Anderson Cancer Center Houston, Texas, United States
- Huntsman Cancer Institute Salt Lake City, Utah, United States
Active, Not Recruiting
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
NCT04128748
- Conditions
- Acute Myeloid Leukemia, Blasts More Than 10 Percent of Bone Marrow Nucleated Cells, Bone Marrow Diseases, +13 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant
NCT02861417
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +46 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute Leukemia
NCT04262843
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +16 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States